Latest Insider Transactions at Wave Life Sciences Ltd. (WVE)
This section provides a real-time view of insider transactions for Wave Life Sciences Ltd. (WVE). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Wave Life Sciences Ltd. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Wave Life Sciences Ltd.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 04
2022
|
Paul Bolno President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
92,500
+16.43%
|
-
|
|
May 04
2022
|
Chandra Vargeese |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+28.12%
|
-
|
|
Feb 16
2022
|
Michael A. Panzara Officer |
SELL
Open market or private sale
|
Direct |
10,603
-12.27%
|
$21,206
$2.31 P/Share
|
|
Feb 16
2022
|
Paul Bolno President and CEO |
SELL
Open market or private sale
|
Direct |
33,150
-8.07%
|
$66,300
$2.32 P/Share
|
|
Feb 16
2022
|
Chandra Vargeese |
SELL
Open market or private sale
|
Direct |
10,603
-11.99%
|
$21,206
$2.32 P/Share
|
|
Feb 16
2022
|
Chris Francis |
SELL
Open market or private sale
|
Direct |
10,123
-12.9%
|
$20,246
$2.31 P/Share
|
|
Feb 16
2022
|
Kyle Moran Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
9,204
-10.98%
|
$18,408
$2.31 P/Share
|
|
Apr 01
2021
|
Ra Capital Management, L.P. |
BUY
Other acquisition or disposition
|
Indirect |
970,025
+29.61%
|
$4,850,125
$5.61 P/Share
|
|
Mar 24
2021
|
Kyle Moran Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,930
+11.92%
|
$21,860
$2.48 P/Share
|
|
Feb 16
2021
|
Kyle Moran Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,722
-2.41%
|
$17,220
$10.57 P/Share
|
|
Feb 16
2021
|
Chandra Vargeese |
SELL
Open market or private sale
|
Direct |
3,145
-3.55%
|
$31,450
$10.57 P/Share
|
|
Feb 16
2021
|
Michael A. Panzara Officer |
SELL
Open market or private sale
|
Direct |
2,929
-3.28%
|
$29,290
$10.57 P/Share
|
|
Feb 16
2021
|
Paul Bolno President and CEO |
SELL
Open market or private sale
|
Direct |
11,205
-2.65%
|
$112,050
$10.57 P/Share
|
|
Feb 16
2021
|
Chris Francis |
SELL
Open market or private sale
|
Direct |
2,698
-3.32%
|
$26,980
$10.57 P/Share
|
|
Feb 01
2021
|
Kyle Moran Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+41.12%
|
-
|
|
Feb 01
2021
|
Chandra Vargeese |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+36.09%
|
-
|
|
Feb 01
2021
|
Michael A. Panzara Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+35.88%
|
-
|
|
Feb 01
2021
|
Paul Bolno President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
150,000
+26.22%
|
-
|
|
Feb 01
2021
|
Chris Francis |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+38.12%
|
-
|
|
Jan 24
2019
|
Ra Capital Management, L.P. |
BUY
Open market or private purchase
|
Indirect |
263,158
+3.27%
|
$10,000,004
$38.0 P/Share
|
|
Nov 14
2017
|
Ra Capital Management, L.P. |
BUY
Open market or private purchase
|
Indirect |
23,398
+0.31%
|
$561,552
$24.0 P/Share
|
|
Nov 13
2017
|
Ra Capital Management, L.P. |
BUY
Open market or private purchase
|
Indirect |
400,000
+5.07%
|
$9,200,000
$23.3 P/Share
|